Literature DB >> 11406318

Increased expression of the transcription factor E2F1 during dopamine-evoked, caspase-3-mediated apoptosis in rat cortical neurons.

S T Hou1, E Cowan, S Dostanic, I Rasquinha, T Comas, P Morley, J P MacManus.   

Abstract

The transcription factor E2F1 mRNA and protein levels increased in rat cortical neurons in response to dopamine (DA)- or 6-hydroxydopamine (OHDA)-evoked apoptosis. Increased E2F1 protein was detected in the nucleus of neurons by double fluorescent immunocytochemistry using antibodies to E2F1 and NeuN. DA and 6-OHDA induced caspase-3-mediated apoptosis of cortical neurons which was attenuated by the addition of antioxidants or caspase-3 inhibitors to the cultures. Antioxidants prevented DA-evoked neuronal apoptosis, and also attenuated the increase in E2F1 expression. These findings suggest that increased expression of the transcription factor E2F1 may serve as a death signal during DA-evoked neuronal apoptosis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11406318     DOI: 10.1016/s0304-3940(01)01909-7

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  3 in total

1.  Neuropilin-1 is a direct target of the transcription factor E2F1 during cerebral ischemia-induced neuronal death in vivo.

Authors:  Susan X Jiang; Melissa Sheldrick; Angele Desbois; Jacqueline Slinn; Sheng T Hou
Journal:  Mol Cell Biol       Date:  2006-12-18       Impact factor: 4.272

2.  Differential roles for caspase-mediated and calpain-mediated cell death in 1- and 3-week-old rat cortical cultures.

Authors:  Ying Wang; Jacob W Zyskind; Daniel J Colacurcio; Kathryn A Lindl; Jenhao H Ting; Galina Grigoriev; Kelly L Jordan-Sciutto
Journal:  Neuroreport       Date:  2012-12-19       Impact factor: 1.837

3.  Collapsin response mediator protein 3 deacetylates histone H4 to mediate nuclear condensation and neuronal death.

Authors:  Sheng T Hou; Susan X Jiang; Amy Aylsworth; Matthew Cooke; Lei Zhou
Journal:  Sci Rep       Date:  2013       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.